Evidence map›Paper›PMID 27635417›Full record

ArticlePathogens & immunity2016

Natural Killer Cell Diversity in Viral Infection: Why and How Much?

Catherine A Blish

Abstract read
In one paragraph

Article in Pathogens & immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. CXCR6Frontiers in immunology · 2019
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Catherine A BlishDepartment of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford, CA 94305 ; Immunology Program, Stanford University School of Medicine, Stanford, CA 94305.

Funding

Modeling the influence of sex on natural killer cell networksDP2AI112193 · NIAID · STANFORD UNIVERSITY · PI BLISH, CATHERINE A · 2013 to 2015
$2.5M
NIAID NIH HHS DP2 AI112193
6 · The paper itself

Abstract

Natural killer cells are a diverse group of innate lymphocytes that are specialized to rapidly respond to cancerous or virus-infected cells. NK cell function is controlled by the integration of signals from activating and inhibitory receptors expressed at the cell surface. Variegated expression patterns of these activating and inhibitory receptors at the single cell level leads to a highly diverse NK cell repertoire. Here I review the factors that influence NK cell repertoire diversity and its functional consequences for our ability to fight viruses.

Indexed as

diversitylymphocytemass cytometryNK cell or natural killer cellrepertoirevirus

Identifiers

PMID27635417
PMCPMC5021221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.